Europe’s drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc’s
COVID-19 shot, but no "clear causal relationship" could be established between the two.
The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna’s vaccine, Spikevax.
For the latest headlines, follow our Google News channel online or via the app.
Read more: Will add warning about rare heart inflammation to Pfizer, Moderna vaccines, says FDA
Also Read
-
Saudi Arabia approves Moderna COVID-19 vaccine for use
Saudi Arabia’s Food and Drug Authority announced on Friday that it has approved the registration Moderna's coronavirus vaccine in the Kingdom, ... Coronavirus -
UAE approves Moderna’s COVID-19 vaccine for emergency use
The United Arab Emirates has approved Moderna Inc’s COVID-19 vaccine for emergency use, the fifth vaccine to receive such approval by the Gulf Arab ... Coronavirus -
Pfizer, Moderna vaccines could protect against COVID-19 for years: Study
Those who have been vaccinated with Pfizer and Moderna’s COVID-19 vaccines could be protected against the virus for years, a new study found.In ... Coronavirus -
More Moderna COVID-19 shots sent to Taiwan to bolster vaccine rollout
A further 410,000 doses of Moderna Inc’s COVID-19 vaccine will arrive in Taiwan on Wednesday, Deputy Minister of the Interior Chen Tsung-yen said on ... Coronavirus -
Will add warning about rare heart inflammation to Pfizer, Moderna vaccines, says FDA
The US Food and Drug Administration said on Wednesday it plans to move quickly to add a warning about rare cases of heart inflammation in adolescents ... Coronavirus -
Moderna seeks EU, Canada approval to expand use of COVID-19 vaccine in teens
Drugmaker Moderna said on Monday it has submitted applications to the European and Canadian health regulators seeking authorization for the expanded ... Coronavirus -
Moderna says its COVID-19 shot works in kids as young as 12
Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option ... Coronavirus
